Trial
NCT04619433
A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Collaborators
—
Condition
Non-squamous Non-small-cell Lung Cancer
Intervention
Camrelizumab
Why stopped
Terminated by Sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-23